Case Studies
SI Joint Dysfunction After Metastatic Sarcoma
Your download will start automatically once you have provided the following information:
“iFuse TORQ expands opportunities for SI joint stabilization.”
*Consultant for SI-BONE, Inc.
- Provider
- Malcolm R. DeBaun, MD*
- Speciality
- Director of Orthopaedic Trauma Duke University
- Facility
- Duke University Hospital
- Bio
-
Fellowship: Orthopaedic Trauma, Harborview Medical Center, Seattle, WA
Residency: Orthopaedic Surgery, Stanford Un... More
Case Details
- Condition
- Pelvic Trauma
- Product(s)
-
iFuse TORQ
- Patient
- 68 y/o male
SI joint dysfunction after metastatic sarcoma
Patient History:
- 68 y/o male with metastatic liposarcoma
- Mets to right Ilium
- Underwent radiation therapy
- Presented with SI joint pain and physical examination consistent with SI joint dysfunction
- Positive response to diagnostic injection
- Temporary pain relief with SI joint injection (10 days)
- Wanted to avoid open procedure
Surgical Treatment:
Percutaneous Right SI joint Fixation x 2 iFuse TORQ® implants
Post-op:1,2
- Tolerated procedure well
- Immediate weight bearing as tolerated
- Marked pain improvement at 2 weeks post-op
- Patient very satisfied with minimally invasive option
- No assisted devices required
1Patient results may vary
2Data on file, STACI Study, SI-BONE, Inc.
Healthcare professionals should refer to the Instructions For Use for indications, contraindications, warnings, and precautions at https://si-bone.com/label.
There are potential risks associated with iFuse procedures. They may not be appropriate for all patients and all patients may not benefit.
For information about the risks, visit https://si-bone.com/risks.